Interleukin-6 Receptor Polymorphism Attenuates Clonal Hematopoiesis-Mediated Coronary Artery Disease Risk Among 451 180 Individuals in the UK Biobank-Reference-Cited by-同舟云学术

Interleukin-6 Receptor Polymorphism Attenuates Clonal Hematopoiesis-Mediated Coronary Artery Disease Risk Among 451 180 Individuals in the UK Biobank

Author:

Vlasschaert Caitlyn¹,Heimlich J. Brett²,Rauh Michael J.³^ORCID,Natarajan Pradeep⁴⁵⁶^ORCID,Bick Alexander G.⁷^ORCID

Affiliation:

1. Department of Medicine (C.V.), Queen’s University, Kingston, Ontario, Canada.

2. Division of Cardiology (J.B.H.), Vanderbilt University Medical Center, Nashville, TN.

3. Department of Pathology and Molecular Medicine (M.J.R.), Queen’s University, Kingston, Ontario, Canada.

4. Cardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital, Boston (P.N.).

5. Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA (P.N.).

6. Department of Medicine, Harvard Medical School, Boston, MA (P.N.).

7. Division of Genetic Medicine, Department of Medicine (A.G.B.), Vanderbilt University Medical Center, Nashville, TN.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference5 articles.

5. A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic datasets.;Vlasschaert C;medRxiv

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献